ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Orgenesis Inc (EM)

Orgenesis Inc (EM) (ORGS)

0.40
0.00
( 0.00% )
更新日時: 09:00:00

Orgenesis Inc (EM) (ORGS) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.40
( - )
買値
0.00
売値
0.00
出来高
-
平均取引量 (3 か月)
US$ 1,369
財務取引量
-
0.00 日の範囲 0.00
0.0001 52 週間の範囲 1.51
時価総額
企業価値
22.069M
前日終値
0.40
始値
-
時刻
最終取引時間
-
VWAP
-
歳入
1.04M
純利益
-48.17M
発行済株式数
9,799,538
浮動株比率 (%)
37.17%
機関投資家保有比率 (%)
0.52%
配当利回り
PER
-0.03
株価売上高倍率 (PSR)
3.79
1 株当たり利益 (EPS)
-11.44
ベータ
3.15

Orgenesis Inc (EM) について

Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produce... Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Germantown, United States
設立
2026
Orgenesis Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker ORGS. The last closing price for Orgenesis (EM) was US$0.40. Over the last year, Orgenesis (EM) shares have traded in a share price range of US$ 0.0001 to US$ 1.51.

Orgenesis (EM) currently has 9,799,538 shares in issue. The market capitalisation of Orgenesis (EM) is US$3.92 million. Orgenesis (EM) has a price to earnings ratio (PE ratio) of -0.03.

ORGS 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.3533756.5310492510.04670.40.04676750.4CS
40.241500.160.520.04674890.41136512CS
120.241500.160.8450.00114250.31823666CS
260.25166.6666666670.150.8450.00111480.29981184CS
52-0.95-70.37037037041.351.510.000115550.468724CS
156-8.86-95.68034557249.269.260.000165651.81327655CS
260-8.86-95.68034557249.269.260.000164661.81327655CS

ORGS - Frequently Asked Questions (FAQ)

What is the current Orgenesis Inc (EM) share price?
The current share price of Orgenesis Inc (EM) is US$ 0.40
How many Orgenesis Inc (EM) shares are in issue?
Orgenesis Inc (EM) has 9,799,538 shares in issue
What is the market cap of Orgenesis Inc (EM)?
The market capitalisation of Orgenesis Inc (EM) is USD 3.92M
What is the 1 year trading range for Orgenesis Inc (EM) share price?
Orgenesis Inc (EM) has traded in the range of US$ 0.0001 to US$ 1.51 during the past year
What is the PE ratio of Orgenesis Inc (EM)?
The price to earnings ratio of Orgenesis Inc (EM) is -0.03
What is the cash to sales ratio of Orgenesis Inc (EM)?
The cash to sales ratio of Orgenesis Inc (EM) is 3.79
What is the registered address of Orgenesis Inc (EM)?
The registered address for Orgenesis Inc (EM) is 20271 Goldenrod Lane, Germantown, Maryland, 20876
What is the Orgenesis Inc (EM) website address?
The website address for Orgenesis Inc (EM) is orgenesis.com
Which industry sector does Orgenesis Inc (EM) operate in?
Orgenesis Inc (EM) operates in the Biotechnology & Life Sciences sector

ORGS 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock